Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sincere CoTSE:7782 -1.50%73 EPS without NRI is 円26.67 as of Dec. 2025. GuruFocus rates TSE:7782 with a GF Score™ of 73/100 and a GF Value™ of 円684.54 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 661 Medical Devices & Instruments companies, Sincere Co ranks better than 82% on this metric.
Sincere Co's earnings per share without non-recurring items for the
three
months ended in Dec. 2025 was 円0.00.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 円26.67.
During the past 12 months, Sincere Co's average earnings per share (NRI) Growth Rate was 3.40% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 35.30% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 27.50% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Sincere Co's EPS without NRI or its related term are showing as below:
TSE:7782'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -44.6 Med: 17.7 Max: 60.4
Current: 35.3
During the past 12 years, Sincere Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 60.40% per year. The lowest was -44.60% per year. And the median was 17.70% per year.
TSE:7782's 3-Year EPS without NRI Growth Rate is ranked better than 82% of 661
companies
in the Medical Devices & Instruments industry
Industry Median: 8.2
vs TSE:7782: 35.30
Sincere Co's EPS (Diluted) for the
three
months ended in Dec. 2025 was 円0.00.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円23.00.
Sincere Co's EPS (Basic) for the
three
months ended in Dec. 2025 was 円0.00.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was 円23.00.
Sincere Co (TSE:7782) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Sincere Co EPS without NRI Related Terms
Sincere Co EPS without NRI Historical Data
* Premium members only.
The historical data trend for Sincere Co's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7782 vs ISRG, BDX, MDLN: EPS without NRI Comparison
For the Medical Instruments & Supplies subindustry, Sincere Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sincere Co PE Ratio without NRI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sincere Co's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Sincere Co's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円26.67
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sincere Co (TSE:7782) has a EPS without NRI of 円26.67 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Sincere Co and its competitors. According to the industry distribution chart, Sincere Co ranks #119 out of 661 companies in the Medical Devices & Instruments industry, placing it in the top 18%.
Is Sincere Co's EPS without NRI too high?
Sincere Co's current EPS without NRI is 円26.67. Based on the distribution chart, Sincere Co ranks #119 out of 661 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sincere Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sincere Co's EPS without NRI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sincere Co ranks #119 out of 661 companies for EPS without NRI. This places Sincere Co in the top 18% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 8.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.20, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Sincere Co and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sincere Co's current EPS without NRI is 円26.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sincere Co stock overvalued right now?
Based on GuruFocus' analysis, Sincere Co (TSE:7782) is currently considered Significantly Undervalued. The stock's GF Value™ is 円684.54, compared to a current price of 円460.00 — trading 32.8% below its estimated fair value. The current EPS without NRI is 円26.67. Sincere Co's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Sincere Co (TSE:7782), the current EPS without NRI is 円26.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sincere Co (TSE:7782) Overvalued in 2026?
Based on GuruFocus' analysis, Sincere Co stock appears to be undervalued.
The current stock price of 円460.00 is trading 32.8% below its estimated GF Value™ of 円684.54.
GuruFocus considers Sincere Co to be Significantly Undervalued.
Key valuation signals for TSE:7782:
EPS without NRI: 円26.67
GF Value™: 円684.54 vs. price of 円460.00 (32.8% below fair value)
No single metric tells the full story. See the TSE:7782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sincere Co Ltd is a Japanese firm engaged in the manufacturing and sale of contact lens.As a company that manufactures and sells contact lenses, which are high-regulated medical devices, it place the highest priority on product safety and quality control, while working closely with company's customers to develop a variety-of-products and sell them at affordable prices to please as many customers as possible. The company opperates domestically as well as internationally.
73GF Score
Get the complete analysis for TSE:7782
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7782 has been successfully added to your 
